Immune reaction and regulation in transplantation based on pluripotent stem cell technology
Abstract The development of pluripotent stem cell (PSC)-based technologies provides us a new therapeutic approach that generates grafts for transplantation. In order to minimize the risk of immune reaction, the banking of induced pluripotent stem cells (iPSCs) from donors with homozygous human leuko...
Main Authors: | Ryo Otsuka, Haruka Wada, Tomoki Murata, Ken-ichiro Seino |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Inflammation and Regeneration |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41232-020-00125-8 |
Similar Items
-
Evaluation of immunosuppression protocols for MHC-matched allogeneic iPS cell-based transplantation using a mouse skin transplantation model
by: Tomoki Kamatani, et al.
Published: (2022-02-01) -
Hematopoietic stem cell transplantation induces immunologic tolerance in renal transplant patients via modulation of inflammatory and repair processes
by: Wu Duojiao, et al.
Published: (2012-08-01) -
Retrotransposons in pluripotent stem cells
by: Jingwen Wang, et al.
Published: (2020-06-01) -
TGFβ signalling is required to maintain pluripotency of human naïve pluripotent stem cells
by: Anna Osnato, et al.
Published: (2021-08-01) -
The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives
by: Xin Liu, et al.
Published: (2017-06-01)